切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2021, Vol. 17 ›› Issue (02) : 152 -158. doi: 10.3877/cma.j.issn.1673-5250.2021.02.005

所属专题: 文献

论著

长效长方案促排卵前采取高纯度人尿促性素预处理的临床分析
包莉莉, 杨波(), 王冬雪, 李冬秀   
  • 收稿日期:2020-09-09 修回日期:2021-03-09 出版日期:2021-04-01
  • 通信作者: 杨波

Clinical analysis of high-purity human postmenopausal gonadotropin pretreatment before ovarian stimulation in long-acting protocol

Lili Bao, Bo Yang(), Dongxue Wang, Dongxiu Li   

  • Received:2020-09-09 Revised:2021-03-09 Published:2021-04-01
  • Corresponding author: Bo Yang
  • Supported by:
    Science and Technology Foundation for Youths of Hebei Health and Family Planning Commission(20170947)
引用本文:

包莉莉, 杨波, 王冬雪, 李冬秀. 长效长方案促排卵前采取高纯度人尿促性素预处理的临床分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2021, 17(02): 152-158.

Lili Bao, Bo Yang, Dongxue Wang, Dongxiu Li. Clinical analysis of high-purity human postmenopausal gonadotropin pretreatment before ovarian stimulation in long-acting protocol[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(02): 152-158.

目的

探讨在长效长方案促排卵前,采取高纯度人尿促性素(HP-hMG)预处理,对接受体外受精/卵胞浆内单精子注射(IVF/ICSI)-胚胎移植(ET)助孕的不孕女性临床妊娠结局的影响。

方法

选择2018年1月至2019年8月,于中国人民解放军联勤保障部队第九八零医院生殖医学中心进行IVF/ICSI-ET助孕,并采用长效长方案促排卵的171例卵巢储备功能正常的不孕女性为研究对象。回顾性分析其临床病例资料。根据启动促性腺激素(Gn)前是否采用HP-hMG预处理,将其分为研究组(n=102,采用HP-hMG进行预处理)与对照组(n=69,未进行预处理)。对2组受试者的一般临床资料、接受IVF/ICSI-ET助孕中相关临床指标、ET相关指标、妊娠结局及助孕相关不良反应发生率等,采用独立样本t检验及χ2检验进行统计学比较。本研究经本院伦理委员会批准(审批文号:2020-KY-129),所有受试者均签署知情同意书。

结果

①2组受试者年龄、人体质量指数(BMI)、原发不孕者所占比例、不孕年限、基础窦卵泡计数(AFC),以及基础血清激素,包括卵泡刺激素(FSH)、促黄体激素(LH)、雌二醇及孕酮水平比较,差异均无统计学意义(P>0.05)。②2组受试者降调节后血清FSH、LH、雌二醇及孕酮水平,Gn启动日血清FSH及雌二醇水平,Gn使用时间及剂量,人绒毛膜促性腺激素(hCG)日血清LH、雌二醇及孕酮水平,以及移植日子宫内膜厚度比较,差异亦均无统计学意义(P>0.05)。研究组受试者Gn启动日血清LH水平为(1.27±0.81) IU/L,显著高于对照组的(0.46±0.21) IU/L,并且差异有统计学意义(t=-8.115、P<0.001)。③2组受试者的获卵数、获卵率、MⅡ卵率、正常受精率、优质胚胎率、鲜胚移植率、移植胚胎数、IVF与ICSI比值(IVF/ICSI)、临床妊娠率及自然流产率比较,差异均无统计学意义(P>0.05)。研究组中、重度卵巢过度刺激综合征(OHSS)及卵巢低反应发生率均为0,显著低于对照组的4.4%及5.8%,并且差异均有统计学意义(χ2=4.514、P=0.034,χ2=6.055、P=0.014)。

结论

接受IVF/ICSI-ET助孕不孕女性,在长效长方案促排卵前采取HP-hMG预处理,可在不增加Gn使用时间及剂量前提下,降低OHSS及卵巢低反应发生。

Objective

To explore impacts of pretreatment with high-purity human postmenopausal gonadotropin (HP-hMG) before ovarian stimulation in long-acting protocol on clinical pregnancy outcome of sterile females who took in vitro fertilization/intracytoplasmic sperm injection (IVF/ISCI)-embryo transfer (ET).

Methods

A total of 171 sterile females with normal ovarian reserve to whom long-acting IVF/ICSI-ET program for assisted reproduction in Department of Reproductive Medicine of the 980th Hospital of PLA Joint Logistics Support Force from January 2018 to August 2019, were selected as research subjects.Their clinical case data were retrospectively analyzed. According to whether pretreated with HP-hMG before officially launching gonadotropin (Gn) or not, they were divided into study group (n=102, pretreated with HP-hMG ) and control group (n=69, without pretreatment). The general clinical data, relevant clinical indicators during IVF/ICSI-ET for assisted reproduction, related indicators of ET, pregnancy outcome and the incidence of adverse reactions related to assisted reproduction of two groups were statistically compared by independent-samples t test and chi-square test.This study was approved by the Ethics Committee of our hospital (Approval No. 2020-KY-129), and all subjects signed the informed consents.

Results

①There were no significant differences in age, body mass index (BMI), proportion of primary infertility, duration of infertility, basal antral follicle count (AFC) and basal serum hormone levels, including follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol and progesterone between two groups (P>0.05). ②There were no significant differences in serum FSH, LH, estradiol and progesterone levels after down-regulation, serum FSH and estradiol levels on Gn start-up day, the usage days and dose of Gn, serum LH, estradiol and progesterone levels on human chorionic gonadotrophin (hCG) day, and endometrial thickness on transplantation day between two groups (P>0.05). The serum LH level on Gn start-up day of study group was (1.27± 0.81) IU/L, which was significantly higher than that of (0.46±0.21) IU/L in control group, and the difference was statistically significant (t=-8.115, P<0.001). ③There were no significant differences in number of retrieved oocytes, rate of retrieved oocytes, rate of M Ⅱ oocytes, rate of normal fertilization, rate of high-quality embryos, rate of fresh embryo transfer, number of transferred embryos, ratio of IVF to ICSI (IVF/ICSI), rate of clinical pregnancy and spontaneous abortion between two groups (P>0.05). The incidences of moderate and severe ovarian hyperstimulation syndrome (OHSS) and poor ovarian response in study group were both 0, which were significantly lower than those of 4.4% and 5.8% in control group, and the differences were statistically significant (χ2=4.514, P=0.034; χ2=6.055, P=0.014).

Conclusions

On the premise of not increasing Gn using days and its dosage, the pretreatment with HP-hMG before ovulation induction in long-acting protocol of sterile females who took IVF/ICSI-ET for assisted reproduction can lower the occurrence of OHSS and poor ovarian response.

表1 接受IVF/ICSI-ET助孕的2组受试者一般临床资料比较
表2 2组受试者接受IVF/ICSI-ET助孕中相关临床指标比较(±s)
表3 接受IVF/ICSI-ET助孕的2组受试者ET相关指标、妊娠结局及不良反应比较
[1]
包莉莉,杨波,王冬雪,等. 高纯度人绝经期促性腺激素的应用对IVF/ICSI促排卵中鲜胚移植率的影响[J]. 生殖医学杂志,2019, 28(10): 1179-1183. DOI: 10.3969/j.issn.1004-3845.2019.10.015.
[2]
张少娣,耿嘉瑄,路锦,等. 促性腺激素释放激素激动剂降调节方案对子宫内膜容受性的研究进展[J].中华生殖与避孕杂志,2017,37(8):675-678. DOI: 10.3760/cma.j.issn.2096-2916.2017.08.015.
[3]
刘思邈,邓成艳. 垂体降调节后促性腺激素启动时机的选择[J].生殖医学杂志,2017, 26(11): 1092-1094. DOI: 10.3969/j.issn.1004-3845.2017.11.008.
[4]
van Wely M, Kwan I, Burt AL, et al. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. a cochrane review[J]. Hum Reprod Update, 2012, 18(2):111. DOI:10.1093/humupd/dmr048.
[5]
张婉玉,张冬雅,杨新红,等. 卵巢过度刺激综合征合并卵巢出血的诊治体会-附2例病案报道与文献复习[J]. 中华生殖与避孕杂志,2021, 41(3): 247-251. DOI: 10.3760/cma.j.cn101441-20200331-00175.
[6]
乔杰,马彩虹,刘嘉茵,等.辅助生殖促排卵药物治疗专家共识[J].生殖与避孕,2015,35(4):211-223.DOI: 10.7669/j.issn.0253-357X.2015.04.0211.
[7]
刘琨,张学红,马晓玲,等. 卵巢高反应性不孕患者拮抗剂超促排卵应用探讨[J]. 中国妇幼保健,2019,34(8):1815-1817. DOI: 10.7620/zgfybj.j.issn.1001-4411.2019.08.41.
[8]
骆丽华,刘雨生,季静娟,等.长方案卵巢刺激启动日血黄体生成激素水平作为黄体生成激素添加指标的价值[J].中国实用妇科与产科杂志,2012,28(8):619-623.
[9]
田冬梅,李亨利,朱明辉,等.卵巢储备正常者COH不同阶段添加高纯度人绝经期促性腺激素对IVF-ET结局的影响[J]. 生殖与避孕,2016,36(9): 769-773.DOI: 10.7669/j.issn.0253-357X.2016.09.0769.
[10]
王凤,邓伟芬,廖海珍,等.改良超长方案中促排卵时不同时期添加高纯度尿促性素对助孕结局的影响[J].中华生殖与避孕杂志,2017,37(1):16-21. DOI: 10.3760/cma.j.issn.2096-2916.2017.01.005.
[11]
刘茜桐,田莉,马淳,等.长方案添加HMG时机对供精体外受精-胚胎移植结局的影响[J].生殖医学杂志,2017,26(7):661-665. DOI: 10.3969/j.issn.1004-3845.2017.07.008.
[12]
Balasch J, Fábregues F, Casamitjana R, et al. A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome[J]. Reprod Biomed Online, 2003, 6(3):296-301. DOI:10.1016/s1472-6483(10)61848-2.
[13]
马亚兰,张欣,李丹丹,等.卵巢功能储备正常者拮抗剂方案COH使用过程中添加高纯度人绝经促性腺激素对IVF-ET妊娠结局的影响[J].吉林大学学报(医学版),2018,44(5):1036-1040.DOI: 10.13481/j.1671-587x.20180527.
[14]
李巍巍,许晓燕,高瑞峰,等.长方案促排卵过程中血清LH低于正常值时补充LH对助孕结局的影响[J].华中科技大学学报(医学版),2015,44(3):334-338. DOI: 10.3870/j.issn.1672-0741.2015.03.021.
[15]
Figen TA, Seckin B, Onalan G, et al. Human menopausal gonadotropin versus recombinant FSH in polycystic ovary syndrome patients undergoing in vitro fertilization[J]. Int J Fertil Steril, 2013, 6(4):238-243.
[16]
Arce JC, Smitz J.Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations[J]. Gynecol Endocrinol, 2013, 29(1):46-50. DOI:10.3109/09513590.2012.705379.
[17]
Thuesen LL, Loft A, Egeberg AN,et al. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization[J]. Hum Reprod, 2012, 27(10):3074-3084. DOI:10.1093/humrep/des256.
[18]
McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles[J]. Endocr Rev, 2000, 21(2):200-214. DOI: 10.1210/edrv.21.2.0394.
[19]
魏丽娜,张俊博,赵考考,等.不同治疗方案在体外受精-胚胎移植患者中的临床疗效比较[J/CD]. 中华妇幼临床医学杂志(电子版), 2018,14(3): 317-323. DOI:10.3877/cma.j.issn.1673-5250.2018.03.011.
[1] 张秋阳, 余韶芸, 潘向滢, 金家佳, 夏桦, 赵雪红. 成年体外膜肺氧合患者出血影响因素的Meta 分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 392-398.
[2] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[3] 钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[4] 石皆春, 范子玉, 邢燕. 不同筛查方法预警宫颈原位腺癌的效能[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 575-581.
[5] 唐丹, 姚晓曦, 杨博文, 薛绍龙, 李梦瑶, 韦柳杏, 郄明蓉. 双肾上腺皮质激素样激酶1对子宫内膜样腺癌患者临床特征的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 582-590.
[6] 杜佳丽, 鲍睿, 乔春红, 韩伟. 中孕期宫颈功能不全孕妇经阴道紧急宫颈环扎术后不良妊娠结局预测模型构建[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 403-409.
[7] 霍枫, 李智霞, 季茹, 谭晓宇, 范晓礼, 叶啟发. 以循环标准判定死亡的遗体器官捐献分类标准、实施流程及需要注意的问题[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 213-221.
[8] 李鑫, 邓相奎, 林昌永, 郭勇. 心脏起搏器/心律转复除颤器与体外冲击波碎石相关指南文献解读[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 313-317.
[9] 魏丁, 乔艳艳, 顾兴, 张燕, 李艳燕, 钱卫生, 潘蕾, 高永恒, 金发光. 体外膜肺氧合救治急性呼吸窘迫综合征不良预后危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 363-367.
[10] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[11] 俞慧慧, 尹宗智. 妊娠期胃穿孔[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 209-213.
[12] 鲁珊, 姚蕴珊, 廖色坭, 陈子恩, 张一剑, 蓝健皓, 魏薇, 刘艳杨, 陈艳红, 陈敦金. 妊娠合并急性阑尾炎100例临床研究[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 214-219.
[13] 汪文雁, 郑剑兰, 朱丽慈. 体外受精-胚胎移植术后妊娠患者孕产期风险的临床研究[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 220-226.
[14] 詹维强, 李梦蝶, 涂玉玲, 郭艳, 芦乙滨, 史新格, 许明. 早期CRRT联合VA-ECMO治疗难治性心源性休克的临床效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 260-268.
[15] 曹慧, 刘华, 赵婷奕, 唐茂庆, 韩骐, 于永华. 非酮症高血糖性偏身舞蹈症一例报道及文献回顾[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 501-505.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?